Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/1997
11/26/1997EP0808369A1 GnRH-LEUKOTOXIN CHIMERAS
11/26/1997EP0808329A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
11/26/1997EP0808328A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
11/26/1997EP0808327A1 Proline derivatives useful as inhibitors of human leukocyte elastase
11/26/1997EP0808326A1 Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
11/26/1997EP0808103A1 Protein hydroxylation inhibitors for fibroproliferative disorders
11/25/1997US5691368 Therapy for neurodegenerative disorders
11/25/1997US5691315 Cardiovascular disorders; vasodilator; bronchodilator
11/25/1997US5690905 Peptide-metal ion pharmaceutical labeling method
11/20/1997WO1997043307A1 Compounds inhibiting the association of the pdgf receptor and phosphatidylinositol 3-kinase and their use
11/20/1997WO1997043306A1 Neuroactive peptides
11/20/1997WO1997043305A1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation
11/20/1997WO1997043289A1 Large synthetic compounds based on electron donor and electron acceptor interactions
11/20/1997WO1997043246A1 Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives
11/20/1997WO1997043232A1 Novel substance library and supramolecular complexes produced therewith
11/20/1997DE19619373A1 Neue Substanzbibliothek und damit hergestellte supramolekulare Komplexe New compound library and supramolecular complexes produced thereby
11/20/1997CA2254343A1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation
11/20/1997CA2252815A1 Novel substance library and supramolecular complexes prepared therewith
11/19/1997EP0807638A1 Inhibitors and substrates of thrombin
11/19/1997EP0719279B1 Process for purifying 1- n(2 -((s)-ethoxycarbonyl)-3-phenylpropyl)-n6 -trifluoroacetyl]-l-lysyl-l-prolin (lisinopril(tfa)ethylester)
11/19/1997CN1165521A Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides
11/18/1997US5688992 Compounds for treatment of signaling pathways in immune disfunction, cancer and diabetes
11/18/1997US5688946 Amino acid derivatives having renin inhibiting activity
11/18/1997US5688928 Phenylboronic acid complexing reagents derived from aminosalicylic acid
11/18/1997US5688913 CS-1 peptidomimetics, compositions and methods of using the same
11/18/1997US5688783 Salinamides
11/18/1997US5688771 Lipophilic oligopeptides with immunomodulating activity
11/18/1997US5688760 Polypeptides having bone resorption inhibitory activity comprising PTHrP-derived sequences
11/18/1997US5688513 Immunology with polypeptides against eimeria and coccidiosis
11/13/1997WO1997042501A1 Phosphotyrosine mimics and methods for identifying and using same
11/13/1997WO1997042216A1 Auto-deconvoluting combinatorial libraries
11/13/1997CA2253776A1 Phosphotyrosine mimics and methods for identifying and using same
11/13/1997CA2252408A1 Auto-deconvoluting combinatorial libraries
11/12/1997EP0806432A1 Glutathione monoester sulfonate
11/12/1997EP0805817A1 Thiol derivatives with metallopeptidase inhibitory activity
11/12/1997EP0805816A1 Compounds with growth hormone releasing properties
11/12/1997CN1164537A New pseudopeptides derived from neurokinins, process for preparing them and pharmaceutical compositions contianing them
11/12/1997CN1036399C Method for preparation of tripeptide antithrombotic agents
11/11/1997US5686628 Proline derivatives
11/11/1997US5686622 Thiazolidine derivatives, their preparation and the medicaments containing the same
11/11/1997US5686469 Antiinflammatory agents
11/11/1997US5686424 For treating inflammation
11/11/1997US5686423 Di-and tri-peptide mimetic compounds for Parkinson's disease
11/11/1997US5686422 Synthetic inhibitors of mammalian collagenase
11/11/1997US5686421 Hydantoin derivates
11/11/1997US5686420 Thyrotropin-releasing hormone analogs and method of use
11/11/1997US5686419 Basic α-aminoalkylphosphonate derivatives
11/11/1997US5686417 Peptide T and related peptides in the treatment of HTLV-1 myelopathy and multiple sclerosis
11/11/1997US5686068 Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof
11/06/1997WO1997041443A2 Method for screening compounds
11/06/1997WO1997041148A1 Specific immunophilin ligands as antiasthmatics and immunosuppressants
11/06/1997WO1997041115A1 5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINES
11/06/1997CA2251813A1 5,6,7,8-tetrahydropyrido¬2,3-d|pyrimidines
11/05/1997EP0805381A2 Control unit for an irrigation system
11/05/1997EP0805149A1 Novel 2,3-diketopiperazine derivative or salt thereof
11/05/1997EP0804481A1 Somatostatin derivatives and their radiolabelled products
11/05/1997EP0804466A1 Novel tetrapeptides, their manufacture and use
11/05/1997EP0804465A1 Novel elastase inhibitors
11/05/1997EP0804464A1 Aromatic heterocyclic derivatives as enzyme inhibitors
11/05/1997EP0804463A1 Neurokinine (tachykinine) antagonists
11/05/1997EP0804460A1 Conformationally constrained reverse-turn library and methods relating thereto
11/05/1997EP0804459A1 Therapeutic compound - fatty acid conjugates
11/05/1997EP0804451A1 Lung cancer marker
11/05/1997EP0804418A2 Platelet aggregation inhibitors
11/05/1997EP0804217A2 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
11/05/1997EP0804216A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
11/05/1997EP0804180A1 Method of inhibiting cathepsin k
11/05/1997EP0655067B1 Beta-aminoalkyl and beta-n-peptidylaminoalkyl boronic acids
11/05/1997CN1164237A New peptides with immunomodulatory effects
11/05/1997CN1164192A Multicatalytic protease inhibitors
11/04/1997US5684132 Preparation of protected amines or alkylated amino acids
11/04/1997US5684127 Tetrapeptides deriving from dalbaheptide antibiotics
11/04/1997US5684016 Method of treating cardiac insufficiency
10/1997
10/30/1997WO1997040070A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
10/30/1997WO1997040066A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997WO1997040065A2 Substrates and inhibitors of proteolytic enzymes
10/30/1997WO1997040058A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997WO1997040023A1 Compounds with growth hormone releasing properties
10/30/1997CA2252761A1 Compounds with growth hormone releasing properties
10/30/1997CA2252581A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997CA2252508A1 Substrates and inhibitors of proteolytic enzymes
10/30/1997CA2252458A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
10/30/1997CA2251714A1 Suppression of immune response via inhibition of cathepsin s
10/29/1997EP0802986A1 Methods of determining endogenous thrombin potential (etp) and thrombin substrates for use in said methods
10/29/1997EP0802923A1 3-amino-2-oxo-1-piperidineacetic derivatives as enzyme inhibitors
10/29/1997EP0802922A1 Novel amino acid derivatives, method of producing them and pharmaceutical compositions containing these compounds
10/29/1997EP0802916A1 Low molecular weight bicyclic thrombin inhibitors
10/29/1997EP0802909A2 Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/29/1997EP0672063B1 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
10/29/1997CN1163618A Urokinase receptor ligands
10/29/1997CN1163145A Inhibiting agent for vascular formation
10/28/1997US5681927 Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
10/28/1997US5681925 Trifunctional antithrombin and antiplatelet peptides
10/28/1997US5681844 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors
10/28/1997US5681830 Opioid compounds
10/28/1997US5681821 Detecting protease in cells
10/28/1997US5681541 (oligo or poly)peptides
10/25/1997CA2203466A1 Novel specific immunophilin ligands as antiasthmatics and immunosuppressants
10/23/1997WO1997039026A1 Novel peptides and nootropic agent
10/23/1997WO1997039024A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability